Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0243026 (
sepsis
)
52,417
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sepsis
and septic shock are characterized by prolonged inflammation and delayed resolution, which are associated with suppression of neutrophil apoptosis. The role of the intrinsic apoptotic pathway and intracellular factors in regulation of neutrophil apoptosis remain incompletely understood. We previously reported that the nuclear factor
MNDA
(myeloid nuclear differentiation antigen) is fundamental to execution of the constitutive neutrophil death program. During neutrophil apoptosis
MNDA
is cleaved by caspases and relocated to the cytoplasm. However, when challenged with known mediators of
sepsis
, human neutrophils of healthy donors or neutrophils from patients with
sepsis
exhibited impaired
MNDA
relocation/cleavage parallel with myeloid cell leukemia-1 (MCL-1) accumulation and suppression of apoptosis.
MNDA
knockdown in a model cell line indicated that upon induction of apoptosis,
MNDA
promotes proteasomal degradation of MCL-1, thereby aggravating mitochondrial dysfunction. Thus,
MNDA
is central to a novel nucleus-mitochondrion circuit that promotes progression of apoptosis. Disruption of this circuit contributes to neutrophil longevity, thereby identifying
MNDA
as a potential therapeutic target in
sepsis
and other inflammatory pathologies.
...
PMID:Myeloid nuclear differentiation antigen, neutrophil apoptosis and sepsis. 2329 39